Monitoring Variants of Concern
On November 26, 2021, both WHO and ECDC designated B.1.1.529 as a Variant of Concern (VOC) and named it Omicron. Siemens Healthineers has conducted internal assessments to confirm that this new variant is unlikely to impact the performance of the CLINITEST® Rapid COVID-19 Antigen Test. Siemens Healthineers is committed to monitoring all current and emerging Variants of Concern (VOC) to ensure the test results remain accurate and reliable.
Scalable COVID-19 antigen testing in 15 minutes
The CLINITEST® Rapid COVID-19 Antigen Test provides fast and accurate results wherever you need them most. The test has been confirmed to detect all current Variants of Concern, including the Delta variant, and it is easy to administer using either the nasal or nasopharyngeal swab methods. Results are available in 15 minutes.
Simple procedure, reliable results
The lateral flow CLINITEST Rapid COVID-19 Antigen Test, distributed by Siemens Healthineers, is easy to administer by any trained professional in virtually any setting, without special equipment. When used as part of a comprehensive strategy, the CLINITEST Rapid COVID-19 Antigen Test can help communities stay ahead of the spread of COVID-19, even in the face of emerging variants.
Download the IFU
Official instructions for use for the CLINITEST COVID-19 Rapid Antigen Test:
Accessible testing, where you need it most
The CLINITEST Rapid COVID-19 Antigen Test can be used to test symptomatic or asymptomatic patients in a wide variety of settings.